Gilead Sciences, Inc. (GILD)
145.51
-3.35
(-2.25%)
USD |
NASDAQ |
Aug 28, 12:58
Gilead Sciences Total Return Price : 145.51 for Aug. 28, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| August 27, 2026 | 148.86 |
| August 26, 2026 | 148.09 |
| August 25, 2026 | 148.77 |
| August 24, 2026 | 146.74 |
| August 21, 2026 | 146.12 |
| August 20, 2026 | 143.44 |
| August 19, 2026 | 147.60 |
| August 18, 2026 | 143.44 |
| August 17, 2026 | 138.92 |
| August 14, 2026 | 138.36 |
| August 13, 2026 | 138.14 |
| August 12, 2026 | 135.87 |
| August 11, 2026 | 135.77 |
| August 10, 2026 | 133.06 |
| August 07, 2026 | 133.21 |
| August 06, 2026 | 130.86 |
| August 05, 2026 | 131.76 |
| August 04, 2026 | 135.25 |
| August 03, 2026 | 131.15 |
| July 31, 2026 | 130.21 |
| July 30, 2026 | 131.28 |
| July 29, 2026 | 132.73 |
| July 28, 2026 | 134.32 |
| July 27, 2026 | 130.52 |
| July 24, 2026 | 129.31 |
| Date | Value |
|---|---|
| July 23, 2026 | 130.86 |
| July 22, 2026 | 130.34 |
| July 21, 2026 | 130.28 |
| July 20, 2026 | 133.21 |
| July 17, 2026 | 134.28 |
| July 16, 2026 | 136.30 |
| July 15, 2026 | 131.70 |
| July 14, 2026 | 130.04 |
| July 13, 2026 | 131.40 |
| July 10, 2026 | 129.83 |
| July 09, 2026 | 134.84 |
| July 08, 2026 | 135.82 |
| July 07, 2026 | 136.36 |
| July 06, 2026 | 129.61 |
| July 02, 2026 | 131.27 |
| July 01, 2026 | 125.97 |
| June 30, 2026 | 126.34 |
| June 29, 2026 | 126.33 |
| June 26, 2026 | 127.88 |
| June 25, 2026 | 123.84 |
| June 24, 2026 | 125.16 |
| June 23, 2026 | 125.05 |
| June 22, 2026 | 124.87 |
| June 18, 2026 | 123.76 |
| June 17, 2026 | 125.45 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Vertex Pharmaceuticals, Inc. | 542.66 |
| AbbVie, Inc. | 256.83 |
| Regeneron Pharmaceuticals, Inc. | 790.29 |
| Amgen, Inc. | 432.22 |
| Biogen, Inc. | 217.28 |